clarithromycin has been researched along with Acute Myelogenous Leukemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, N; Kameoka, Y; Kitadate, A; Kobayashi, T; Miura, M; Nara, M; Sato, H; Takahashi, N; Yamashita, T; Yoshioka, T | 1 |
| Baluch, A; Pasikhova, Y; Snyder, M | 1 |
| Hashino, S; Ohe, M | 1 |
3 other study(ies) available for clarithromycin and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Safe administration and pharmacokinetic monitoring of crushed venetoclax tablets with posaconazole and clarithromycin via percutaneous endoscopic gastrostomy tube in a patient with acute myeloid leukemia.
Topics: Bridged Bicyclo Compounds, Heterocyclic; Clarithromycin; Gastrostomy; Humans; Leukemia, Myeloid, Acute; Sulfonamides; Tablets; Triazoles | 2022 |
Successful management of Mycobacterium haemophilum lower extremity cutaneous infection in a matched-unrelated donor stem cell transplant recipient.
Topics: Anti-Bacterial Agents; Biopsy; Cellulitis; Ciprofloxacin; Clarithromycin; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lower Extremity; Middle Aged; Mycobacterium haemophilum; Mycobacterium Infections, Nontuberculous; Opportunistic Infections; Rifabutin; Tacrolimus; Unrelated Donors | 2017 |
[Successful treatment with clarithromycin for Mixed phenotype acute leukemia, T/myeloid, NOS].
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Myeloid, Acute; Pneumonia, Bacterial; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone | 2010 |